UnknownPhase 3NCT00004128

Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Studying Acute erythroid leukemia

Last synced from ClinicalTrials.gov May 3, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Principal Investigator: Roel Willemze, MD, PhD, Ph.D
Leiden University Medical Center
Intervention: aldesleukin(biological)
Enrollment: 2000 enrolled
Eligibility: 15-60 years · All sexes
Timeline: 1999

Collaborators

Gruppo Italiano Malattie EMatologiche dell'Adulto

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00004128 on ClinicalTrials.gov

Other trials for Acute erythroid leukemia

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE2NCT00658814
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
National Cancer Institute (NCI)

See all trials for Acute erythroid leukemia →

← Back to all trials